USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Environmental Health Research
City: Lexington
State: KY
Zip+4: 40503
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $189,503.00 4
SBIR Phase II $416,000.00 1

Award List:

MANY COMMERCIAL DYES HAVE A BENZIDINE BASE.

Award Year / Program / Phase: 1985 / SBIR / Phase I
Agency: HHS
Principal Investigator: Karen h. brock , PRINCIPAL INVESTIGATOR
Award Amount: $49,915.00
Abstract:
Many commercial dyes have a benzidine base. evidence suggests a causal relationship between these dyes and bladder cancer in humans. routine short-term tests are inefficient for detection of the benzidine base dyes without modifications. short-term tests coupled to activation systems from rodent… More

INITIATION-PROMOTION BIOASSAY IN MOUSE LIVER

Award Year / Program / Phase: 1987 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael A Pereira
Award Amount: $40,000.00

INITIATION-PROMOTION BIOASSAY IN MOUSE LIVER

Award Year / Program / Phase: 1989 / SBIR / Phase II
Agency: HHS
Principal Investigator: Michael A Pereira
Award Amount: $416,000.00
Abstract:
Short-term/limited bioassays for the detection of chemical carcinogens, tumor initiators, and tumor promoters have been recognized as important components to the determinationof the carcinogenic hazard of environmental chemicals and complex mixtures. these bioassays are useful to determine (1)… More

MOLECULAR ANALYSIS OF DELETION MUTATIONS

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: James C Fuscoe
Award Amount: $49,588.00
Abstract:
The objective is the development of methods and reagents for use in the study of deletion mutations at the molecular level. such technology has not been developed for the analysis of deletion mutations which are induced by an important class of environmental mutagens/carcinogens and is necessary for… More

Drug Potential of Anticonvulsants in Stroke Therapy

Award Year / Program / Phase: 1993 / SBIR / Phase I
Agency: HHS
Principal Investigator: Pankaja K. Kadaba
Award Amount: $50,000.00
Abstract:
There is evidence that the excitotoxic action resulting from excessive accumulation of L-glutamate plays a prominent role in human epilepsy and brain ischemia/stroke, leading to neuronal dysfunction and cell death. The triazolines and the aminoalkylpyridine metabolite analogues are a group of novel… More